A Comprehensive Review of CBD's Effects on Brain Function Found Promise for Multiple Conditions but Called for Better Regulation
CBD shows potential for managing epilepsy, psychosis, anxiety, pain, and inflammation, with emerging evidence for effects on sleep, motor control, and cognition, but products remain largely unregulated and quality and safety standards are lacking.
Quick Facts
What This Study Found
CBD has documented therapeutic effects for epileptic seizures, psychosis, anxiety, neuropathic pain, and inflammation. Emerging evidence suggests effects on sleep, motor control, cognition, and memory. CBD influences brain function through multiple mechanisms beyond the endocannabinoid system. Current products do not meet most food safety authority standards for dietary supplements.
Key Numbers
No specific quantitative outcomes. Review covers epilepsy, Alzheimer's, Huntington's, Parkinson's, psychosis, anxiety, depression, substance use disorders, sleep, motor control, and cognition.
How They Did This
Comprehensive narrative review synthesizing evidence on CBD's biomolecular properties, mechanisms of action, effects on neurological and mental disorders, behavioral effects, and regulatory considerations.
Why This Research Matters
CBD has become one of the most popular wellness products globally, but there is a stark gap between consumer interest and regulatory oversight. This review maps what is actually known versus what is marketed.
The Bigger Picture
The disconnect between CBD's commercial availability and its regulatory status creates a situation where millions of people use products with unverified quality, inconsistent dosing, and uncertain safety. This review argues for responsible research and regulation.
What This Study Doesn't Tell Us
Narrative review without systematic methodology. Many covered topics have limited human evidence. Cannot address all CBD product variations and formulations. Regulatory landscape varies by country.
Questions This Raises
- ?Will regulatory frameworks catch up with CBD product proliferation?
- ?Which of CBD's many proposed mechanisms is most clinically relevant?
Trust & Context
- Key Stat:
- CBD products remain largely unregulated despite widespread therapeutic claims
- Evidence Grade:
- Comprehensive narrative review covering multiple conditions. Evidence quality varies from strong (epilepsy) to preliminary (cognition).
- Study Age:
- Published in 2023.
- Original Title:
- Cannabidiol and brain function: current knowledge and future perspectives.
- Published In:
- Frontiers in pharmacology, 14, 1328885 (2023)
- Authors:
- Schouten, Moniek, Dalle, Sebastiaan(2), Mantini, Dante, Koppo, Katrien
- Database ID:
- RTHC-04921
Evidence Hierarchy
Summarizes existing research on a topic.
What do these levels mean? →Frequently Asked Questions
What conditions does CBD actually help with?
The strongest evidence supports CBD for epileptic seizures (FDA-approved). There is also meaningful evidence for psychosis, anxiety, and neuropathic pain. Evidence for cognition, sleep, and neurodegenerative diseases is emerging but preliminary.
Are CBD products safe?
Most CBD products do not meet food safety authority standards. Product quality, consistency, and accurate labeling remain significant concerns in the largely unregulated market.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
Cite This Study
https://rethinkthc.com/research/RTHC-04921APA
Schouten, Moniek; Dalle, Sebastiaan; Mantini, Dante; Koppo, Katrien. (2023). Cannabidiol and brain function: current knowledge and future perspectives.. Frontiers in pharmacology, 14, 1328885. https://doi.org/10.3389/fphar.2023.1328885
MLA
Schouten, Moniek, et al. "Cannabidiol and brain function: current knowledge and future perspectives.." Frontiers in pharmacology, 2023. https://doi.org/10.3389/fphar.2023.1328885
RethinkTHC
RethinkTHC Research Database. "Cannabidiol and brain function: current knowledge and future..." RTHC-04921. Retrieved from https://rethinkthc.com/research/schouten-2023-cannabidiol-and-brain-function
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.